U.S. Renal Data System. 2019 USRDS annual data report: Section 2: End-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2018.
Nguyen DB, et al. National healthcare safety network (NHSN) dialysis event surveillance report for 2014. Clin J Am Soc Nephrol 2017; 12:1139–1146.
Fisher M, et al. Prevention of bloodstream infections in patients undergoing hemodialysis. Clin J Am Soc Nephrol 202; 15:132–151.
Centers for Disease Control and Prevention. Dialysis safety core interventions, 2016. https://www.cdc.gov/dialysis/prevention-tools/core-interventions.html.
Mimoz O, et al. Skin antisepsis with chlorhexidine–alcohol versus povidone iodine–alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): An open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 2015; 386:2069–2077.
Rosenblum A, et al. Hemodialysis catheter care strategies: A cluster-randomized quality improvement initiative. Am J Kidney Dis 2014; 63:259–267.
Apata IW, et al. Chlorhexidine-impregnated transparent dressings decrease catheter-related infections in hemodialysis patients: A quality improvement project. J Vasc Access 2017; 18:103–108.
Hymes JL, et al. Dialysis catheter-related bloodstream infections: A cluster-randomized trial of the ClearGuard HD antimicrobial barrier cap. Am J Kidney Dis 2016; 69:220–227.
Brunelli SM, et al. Cluster-randomized trial of devices to prevent catheter-related bloodstream infection. J Am Soc Nephrol 2018; 29:1336–1343.
Landry DL, et al. Emergence of gentamycin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol 2010; 5:1799–1804.
Moran J, et al. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Am J Kidney Dis 2012; 59:102–107.
Moore CL, et al. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients. Clin J Am Soc Nephrol 2014; 9:1232–1239.
Hemmelgarn BR, et al. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. N Engl J Med 2011; 364:303–312.
Agarwal A, et al. Lock-It-100: Crmd003, a novel taurolidine-based catheter lock solution reduces catheter-related bloodstream infections in hemodialysis [Abstract]. Am J Kidney Dis 2019; 73:898–902.
Broom JK, et al. A randomized controlled trial of heparin versus ethanol lock therapy for the prevention of catheter associated infection in haemodialysis patients—the HEALTHY-CATH trial. BMC Nephrol 2012; 13:146.
Sofroniadou S, et al. Ethanol combined with heparin as a locking solution for the prevention of catheter related blood stream infections in hemodialysis patients: A prospective randomized study. Hemodial Int 2017; 21:498–506.
El-Hennawy AS, et al. Sodium bicarbonate catheter lock solution reduces hemodialysis catheter loss due to catheter-related thrombosis and blood stream infection: An open-label clinical trial. Nephrol Dial Transplant 2019; 34:1739–1745.
Patel PR, et al. Bloodstream infection rates in outpatient hemodialysis facilities participating in a collaborative prevention effort: A quality improvement report. Am J Kidney Dis 2013; 62:322–330.